Article
Plasma microRNA vary in association with the progression of Alzheimer's disease
1 Jan 2022
Abstract excerpt
INTRODUCTION: Early intervention in Alzheimer's disease (AD) requires the development of an easily administered test that is able to identify those at risk. Focusing on microRNA robustly detected in plasma and standardizing the analysis strategy, we sought to identify disease-stage specific biomarkers. METHODS: Using TaqMan microfluidics arrays and a statistical consensus approach, we assessed plasma levels of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
